Published in J Autism Dev Disord on August 01, 2003
An Open Label Study of CM-AT for the Treatment of Children With Autism | NCT02649959
A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study) | NCT02410902
Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry (2011) 2.28
Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab (Lond) (2011) 1.58
Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr (2008) 1.42
Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatr Res (2011) 1.24
Nutritional status of individuals with autism spectrum disorders: do we know enough? Adv Nutr (2015) 1.24
The gluten-free, casein-free diet in autism: results of a preliminary double blind clinical trial. J Autism Dev Disord (2006) 1.08
Alteration of plasma glutamate and glutamine levels in children with high-functioning autism. PLoS One (2011) 1.00
One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders. J Cell Mol Med (2009) 0.99
Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families. Neurotherapeutics (2010) 0.90
Gluten- and casein-free dietary intervention for autism spectrum conditions. Front Hum Neurosci (2013) 0.89
MRI findings in pediatric patients with scurvy. Skeletal Radiol (2014) 0.87
Application of LC-MS/MS analysis of plasma amino acids profiles in children with autism. J Clin Biochem Nutr (2012) 0.85
The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis. Nutr Metab (Lond) (2012) 0.85
Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with Autism Spectrum Disorders. J Autism Dev Disord (2012) 0.84
Zinc in gut-brain interaction in autism and neurological disorders. Neural Plast (2015) 0.83
Acute dietary tryptophan manipulation differentially alters social behavior, brain serotonin and plasma corticosterone in three inbred mouse strains. Neuropharmacology (2014) 0.82
Autism and urinary exogenous neuropeptides: development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory. Anal Bioanal Chem (2007) 0.81
Increased glutamate and homocysteine and decreased glutamine levels in autism: a review and strategies for future studies of amino acids in autism. Dis Markers (2013) 0.81
Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children. PLoS One (2014) 0.81
Prevalence and Predictors of Complementary and Alternative Medicine Use in a Large Insured Sample of Children with Autism Spectrum Disorders. Res Autism Spectr Disord (2015) 0.79
Chronomics of autism and suicide. Biomed Pharmacother (2005) 0.76
Blood Glutamate Levels in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.75
Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature. Amino Acids (2016) 0.75
New Perspective on Impact of Folic Acid Supplementation during Pregnancy on Neurodevelopment/Autism in the Offspring Children - A Systematic Review. PLoS One (2016) 0.75
Tryptophan status in autism spectrum disorder and the influence of supplementation on its level. Metab Brain Dis (2017) 0.75
Parents' and child health professionals' attitudes towards dietary interventions for children with autism spectrum disorders. J Autism Dev Disord (2014) 0.75
Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord (1980) 7.07
The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord (1999) 3.77
Severe nutritional deficiencies in toddlers resulting from health food milk alternatives. Pediatrics (2001) 2.15
Field trial for autistic disorder in DSM-IV. Am J Psychiatry (1994) 1.96
Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry (1996) 1.41
Plasma excitatory amino acids in autism. Invest Clin (1996) 1.12
Perspectives on the nutritional ecology of autistic children. J Autism Dev Disord (1986) 1.06
Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr Scand (1993) 1.01
Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. J Am Acad Child Adolesc Psychiatry (1998) 0.92
Plasma zinc, copper, and amino acid levels in the blood of autistic children. J Autism Child Schizophr (1978) 0.86
Amino compounds and organic acids in CSF, plasma, and urine of autistic children. Biol Psychiatry (1978) 0.86
Low serum tryptophan to large neutral amino acids ratio in idiopathic infantile autism. Biomed Pharmacother (1995) 0.82
Disruptive behavior: a dietary approach. J Autism Child Schizophr (1978) 0.79
Hair amino acids in childhood autism. J Autism Child Schizophr (1974) 0.75
Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol (2010) 7.00
Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics (2005) 4.91
National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol (2006) 4.08
Advanced parental age and the risk of autism spectrum disorder. Am J Epidemiol (2008) 3.30
Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: a multisite collaboration. Pediatrics (2008) 2.88
Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes (2002) 2.85
A replication of the Autism Diagnostic Observation Schedule (ADOS) revised algorithms. J Am Acad Child Adolesc Psychiatry (2008) 2.82
Autism spectrum disorder and co-occurring developmental, psychiatric, and medical conditions among children in multiple populations of the United States. J Dev Behav Pediatr (2010) 2.69
Survival of "pre-viable" infants in the United States. Wien Klin Wochenschr (2005) 2.68
Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem (2003) 2.67
Racial/ethnic disparities in the identification of children with autism spectrum disorders. Am J Public Health (2008) 2.61
Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol (2005) 2.58
Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics (2010) 2.45
Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes (2003) 2.40
A public health collaboration for the surveillance of autism spectrum disorders. Paediatr Perinat Epidemiol (2007) 2.36
Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Res A Clin Mol Teratol (2008) 2.35
Newborn behavioral and physiological responses to circumcision. MCN Am J Matern Child Nurs (2003) 2.09
Extreme obesity and risk of stillbirth among black and white gravidas. Obstet Gynecol (2007) 2.06
Prevalence of cerebral palsy, co-occurring autism spectrum disorders, and motor functioning - Autism and Developmental Disabilities Monitoring Network, USA, 2008. Dev Med Child Neurol (2013) 2.04
Outcomes of Latina women in CenteringPregnancy group prenatal care compared with individual prenatal care. J Midwifery Womens Health (2013) 2.02
Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology (2002) 1.94
Socioeconomic inequality in the prevalence of autism spectrum disorder: evidence from a U.S. cross-sectional study. PLoS One (2010) 1.93
Evaluation of a methodology for a collaborative multiple source surveillance network for autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002. MMWR Surveill Summ (2007) 1.83
Survival of infants with neural tube defects in the presence of folic acid fortification. Pediatrics (2006) 1.72
Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology (2005) 1.68
Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol (2005) 1.68
Subcutaneous tissue reapproximation, alone or in combination with drain, in obese women undergoing cesarean delivery. Obstet Gynecol (2005) 1.62
The ratio of arginine to dimethylarginines is reduced and predicts outcomes in patients with severe sepsis. Crit Care Med (2011) 1.54
Early regression in social communication in autism spectrum disorders: a CPEA Study. Dev Neuropsychol (2005) 1.54
Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011. MMWR Morb Mortal Wkly Rep (2015) 1.52
States Monitoring Assisted Reproductive Technology (SMART) Collaborative: data collection, linkage, dissemination, and use. J Womens Health (Larchmt) (2013) 1.49
Incidence, risk factors, and associated complications of eclampsia. Obstet Gynecol (2011) 1.49
Hepatocytes: critical for glucose homeostasis. Int J Biochem Cell Biol (2004) 1.45
Do differences in accuracy of vital records and hospital discharge data between physician and nurse-midwife attended births matter? Matern Child Health J (2008) 1.44
Sex differences in the evaluation and diagnosis of autism spectrum disorders among children. Disabil Health J (2009) 1.42
Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet Gynecol (2003) 1.40
Should all children be screened for autism spectrum disorders? Yes: merging science, policy, and practice. Am Fam Physician (2011) 1.40
Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. J Perinatol (2004) 1.39
Prevalence of cerebral palsy: Autism and Developmental Disabilities Monitoring Network, three sites, United States, 2004. Disabil Health J (2009) 1.32
A comparison of two surveillance strategies for selected birth defects in Florida. Public Health Rep (2012) 1.30
Olfaction and taste processing in autism. Biol Psychiatry (2007) 1.29
Is there a 'regressive phenotype' of Autism Spectrum Disorder associated with the measles-mumps-rubella vaccine? A CPEA Study. J Autism Dev Disord (2006) 1.26
Childbearing beyond maternal age 50 and fetal outcomes in the United States. Obstet Gynecol (2003) 1.24
Variation by state in outcomes classification for deliveries less than 500 g in the United States. Matern Child Health J (2011) 1.23
A multilevel analysis of individual, household, and neighborhood correlates of intimate partner violence among low-income pregnant women in Jefferson county, Alabama. Am J Public Health (2009) 1.22
Recurrence of ischemic placental disease. Obstet Gynecol (2007) 1.20
Identifying children with autism early? Pediatrics (2007) 1.19
Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection? Birth Defects Res A Clin Mol Teratol (2013) 1.15
Fetal growth risk curves: defining levels of fetal growth restriction by neonatal death risk. Am J Obstet Gynecol (2006) 1.13
Sensitivity of birth certificate reports of birth defects in Atlanta, 1995-2005: effects of maternal, infant, and hospital characteristics. Public Health Rep (2011) 1.13
Mode of delivery and neonatal survival of infants with isolated gastroschisis. Obstet Gynecol (2004) 1.13
Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis. Sci Transl Med (2011) 1.12
Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism. Biol Psychiatry (2004) 1.10
The use of two language tests to identify pragmatic language problems in children with autism spectrum disorders. Lang Speech Hear Serv Sch (2005) 1.10
Selected birth defects data from population-based birth defects surveillance programs in the United States, 2006 to 2010: featuring trisomy conditions. Birth Defects Res A Clin Mol Teratol (2013) 1.10
Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling. Biochim Biophys Acta (2009) 1.09
Randomized controlled trial to improve childhood immunization adherence in rural Pakistan: redesigned immunization card and maternal education. Trop Med Int Health (2010) 1.09
Infantile hypertrophic pyloric stenosis: epidemiology, genetics, and clinical update. Adv Pediatr (2011) 1.08
Birth defects and environmental exposures: logical, diabolical or the devil is in the details? Environ Res (2012) 1.07
Accuracy of assisted reproductive technology information on birth certificates: Florida and Massachusetts, 2004-06. Paediatr Perinat Epidemiol (2014) 1.07
Novel treatments for autistic spectrum disorders. Ment Retard Dev Disabil Res Rev (2005) 1.06
The relative contribution of data sources to a birth defects registry utilizing passive multisource ascertainment methods: does a smaller birth defects case ascertainment net lead to overall or disproportionate loss? J Registry Manag (2011) 1.05
Primary preeclampsia in the second pregnancy: effects of changes in prepregnancy body mass index between pregnancies. Obstet Gynecol (2007) 1.05
Using birth defects registry data to evaluate infant and childhood mortality associated with birth defects: an alternative to traditional mortality assessment using underlying cause of death statistics. Birth Defects Res A Clin Mol Teratol (2007) 1.02
Factors associated with late detection of critical congenital heart disease in newborns. Pediatrics (2013) 1.01
Complementary and alternative medicine treatments for children with autism spectrum disorders. Child Adolesc Psychiatr Clin N Am (2008) 1.01
Significant paternal contribution to the risk of small for gestational age. BJOG (2005) 1.01
Racial disparity in stillbirth among singleton, twin, and triplet gestations in the United States. Obstet Gynecol (2004) 1.00
Shear wave dispersion measures liver steatosis. Ultrasound Med Biol (2011) 1.00
Contribution of prepregnancy body mass index and gestational weight gain to caesarean birth in Canada. BMC Pregnancy Childbirth (2014) 0.99
Obesity and extreme obesity: new insights into the black-white disparity in neonatal mortality. Obstet Gynecol (2008) 0.98
The association between race/ethnicity and major birth defects in the United States, 1999-2007. Am J Public Health (2014) 0.98
Young maternal age and risk of intrapartum stillbirth. Arch Gynecol Obstet (2008) 0.98
Frequency and pattern of documented diagnostic features and the age of autism identification. J Am Acad Child Adolesc Psychiatry (2013) 0.98
Use of complementary and alternative treatments for children with autistic spectrum disorders is increasing. Pediatr Ann (2003) 0.97
Heterogeneous association between engrailed-2 and autism in the CPEA network. Am J Med Genet B Neuropsychiatr Genet (2008) 0.97
Children with cerebral palsy: racial disparities in functional limitations. Epidemiology (2012) 0.97
Familial autoimmune thyroid disease as a risk factor for regression in children with Autism Spectrum Disorder: a CPEA Study. J Autism Dev Disord (2006) 0.97
Prenatal tobacco use and risk of stillbirth: a case-control and bidirectional case-crossover study. Nicotine Tob Res (2008) 0.97
Protein insufficiency and linear growth restriction in phenylketonuria. J Pediatr (2002) 0.96
Birth defects surveillance in Florida: infant death certificates as a case ascertainment source. Birth Defects Res A Clin Mol Teratol (2010) 0.96
The association between major birth defects and preterm birth. Matern Child Health J (2008) 0.96
Epidemiology of bladder and cloacal exstrophies in New York State, 1983-1999. Birth Defects Res A Clin Mol Teratol (2007) 0.95
Advanced maternal age and risk of antepartum and intrapartum stillbirth. J Obstet Gynaecol Res (2008) 0.95
Does access to a medical home differ according to child and family characteristics, including special-health-care-needs status, among children in Alabama? Pediatrics (2007) 0.95
Brief report: Association between behavioral features and gastrointestinal problems among children with autism spectrum disorder. J Autism Dev Disord (2012) 0.95
Pregnancy spacing among women delaying initiation of childbearing. Arch Gynecol Obstet (2008) 0.95
Maternal prepregnancy body mass index and delivery of a preterm infant in missouri 1998-2000. Public Health Nurs (2009) 0.95
A comparison of medical induction and dilation and evacuation for second-trimester abortion. Am J Obstet Gynecol (2002) 0.94
Omphalocele and gastroschisis in the State of New York, 1992-1999. Birth Defects Res A Clin Mol Teratol (2003) 0.94
Childhood pregnancy (10-14 years old) and risk of stillbirth in singletons and twins. J Pediatr (2006) 0.94
Maternal nativity as a risk factor for gastroschisis: a population-based study. Birth Defects Res A Clin Mol Teratol (2009) 0.94
Twenty-five-year survival of children with birth defects in New York State: a population-based study. Birth Defects Res A Clin Mol Teratol (2011) 0.94
Challenges and priorities for surveillance of stillbirths: a report on two workshops. Public Health Rep (2009) 0.94
Maternal race/ethnicity and survival experience of children with congenital heart disease. J Pediatr (2013) 0.94
The role of migration and choice of denominator on the prevalence of cerebral palsy. Dev Med Child Neurol (2013) 0.93
Public Health Practice of Population-Based Birth Defects Surveillance Programs in the United States. J Public Health Manag Pract (2016) 0.93
Racial disparities in perinatal outcomes and pregnancy spacing among women delaying initiation of childbearing. Matern Child Health J (2008) 0.93
Interpregnancy interval and subsequent perinatal outcomes among women delaying initiation of childbearing. J Obstet Gynaecol Res (2008) 0.92
Changes in prepregnancy body mass index between pregnancies and risk of primary cesarean delivery. Am J Obstet Gynecol (2007) 0.92